Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia
Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...
A scientific approach to placenta remedies: What hormones are found in placenta tissue?
The human placenta contains a mixture of substances which may be useful for individual postpartum treatment...
Identification of Pancreatic Cancer Specific Tumor Markers for Early Detection
Pancreatic cancer is the third leading cause of cancer-related death in the US, and expected to become the...